Skip to main content
. Author manuscript; available in PMC: 2016 Apr 26.
Published in final edited form as: Vascul Pharmacol. 2011 Mar 10;55(1-3):2–9. doi: 10.1016/j.vph.2011.03.001

Fig. 4.

Fig. 4

Alogliptin causes rapid NO release from HUVECs in dose and time dependent fashion. A. Dose dependent increase in the NO level after incubating HUVECs with various doses of alogliptin for 5 min. B. Time dependent NO release after incubating HUVECs with 50 μM alogliptin. All experiments were conducted 3 times and values represent mean±SD.